)
Raphael Ognar
Chief Executive Officer,
NKILT Therapeutics
Sessions
-
02-Sep-2025Pau CasalsSpotlight: Beyond capital - What biotech’s need from investors
-
04-Sep-2025Theatre 2Spotlight: Unlocking off-the-shelf potential for cancer patients: building scalable, accessible and fit-for-purpose cell therapy
-
04-Sep-2025PlenaryPanel: Charting the way forward: Where are we heading?